Corriente Advisors’s Turning Point Therapeutics TPTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TPTX
Corriente Advisors's TPTX Position: Q1 2020 in Review
Corriente Advisors sold out of Turning Point Therapeutics (TPTX) in Q1 2020, closing a stake of 285,000 shares — an estimated $17.8M sold.
Corriente Advisors first reported a position in TPTX in Q4 2019 and held it in 1 quarter. The position peaked at $17.8M in Q4 2019. 119 funds tracked by Wall St. Rank hold TPTX as of Q1 2020.
- Corriente Advisors reported no remaining Turning Point Therapeutics position as of Q1 2020 after selling out during the quarter.
- Corriente Advisors sold 285,000 Turning Point Therapeutics shares in Q1 2020, an estimated $17.8M.
- Corriente Advisors first reported a position in Turning Point Therapeutics in Q4 2019 and held it in 1 quarter.
- Corriente Advisors's Turning Point Therapeutics position peaked at $17.8M in Q4 2019.
- 119 funds tracked by Wall St. Rank held Turning Point Therapeutics as of Q1 2020.
Based on Corriente Advisors's 13F filing for Q1 2020, filed 18 May 2020.